<DOC>
	<DOCNO>NCT01788501</DOCNO>
	<brief_summary>This study aim compare efficacy safety tacrolimus/methotrexate cyclosporine/methotrexate graft versus host disease prophylaxis paediatric allogeneic hematopoietic stem cell transplantation patient .</brief_summary>
	<brief_title>Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate Prophylaxis Graft Versus Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Diagnosis hematological malignancy Age 18 year old Serum bilirubin le 1.5 X upper limit normal Aspartate transaminase , Alanine transaminase le 2.5 X upper limit normal Alkaline phosphatase le 2.5 X upper limit normal Serum creatinine le 1.5 X upper limit normal Agrees participate , informed consent sign Evidence HIV infection Documented uncontrolled disease ( infection ) Prior transplantation ( hematopoietic stem cell solid organ )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>